BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 21, 2011
View Archived Issues
Phase II data reported for S*BIO's SB-939
Read More
Phase III study of canakinumab in systemic juvenile idiopathic arthritis completed
Read More
GSK reports topline results from first of eight phase III studies of albiglutide in type 2 diabetes
Read More
Early clinical studies of CTP-499 conducted in healthy subjects
Read More
Pan-tyrosine-protein kinase inhibitor shows potential for treatment of multiple sclerosis
Read More
New VPAC2 receptor agonist demonstrates antihypertensive potential
Read More
New antiarrhythmic agent demonstrates good efficacy and safety in pilot study
Read More
Chinese researchers present new IKK-beta inhibitors
Read More
Cellzome presents novel JAK3 inhibitors
Read More
Scientists at Leo Pharma synthesize novel PDE4 inhibitors
Read More
New puerarin derivative reported by Shandong University
Read More
Cytokinetics discloses new modulators of skeletal muscle contractility
Read More
NCI commences phase I trial of AZD-7451 for gliomas
Read More
Eisai and Novartis Pharma enter agreement on COPD therapies in Japan
Read More
Alnylam Pharmaceuticals licenses InterfeRx to Sylentis
Read More
AstraZeneca receives positive CHMP opinion for vandetanib
Read More
FDA pushes back review date for Takeda's type 2 diabetes therapies
Read More
Hybrigenics initiates phase II trial of inecalcitol for psoriasis
Read More
Shionogi and Shire enter collaboration for two therapeutic agents for ADHD
Read More
Regeneron obtains FDA approval for Eylea
Read More
Starpharma reaches agreement with EMA on phase III program for VivaGel
Read More
Ajinomoto and Interprotein to collaborate on protein-protein interaction inhibitors
Read More
Mologen's phase I/II study of cell-based renal cancer therapy meets primary endpoint
Read More
FDA reaches final decision on Avastin for metastatic breast cancer
Read More
CHMP recommends extended indication for Rebif in patients with early signs of MS
Read More
GSK and Daiichi Sankyo set to launch Rotarix rotavirus vaccine in Japan
Read More